Found 0 matching trials
A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets PHASE2 The present phase II/III, multicenter, randomized, double-blind, parallel g...
Show More Location
Multiple Locations
Learn More & Join Trial
Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women PHASE3 To confirm the superiority of 5 mg daily risedronate as compared to placebo...
Show More Learn More & Join Trial
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer PHASE3 RATIONALE: Preventing bone loss in patients who are undergoing androgen abl...
Show More Location
CCOP - Mayo Clinic Scottsdale Oncology Program
Learn More & Join Trial
Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis PHASE3 The purpose of this study is to develop new treatment options for osteoporo...
Show More Location
Columbia University Medical Center, Harkness Pavilion
Learn More & Join Trial
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer PHASE3 Aromatase inhibitor therapy is in France the adjuvant reference treatment f...
Show More Location
Service de Rhumatology et de Pathologie Osseuse, Hôpital Edouard Herriot
Learn More & Join Trial
Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients. PHASE1 Patients with kidney failure have underlying bone disease at the time of tr...
Show More Location
Montefiore Medical Center
Learn More & Join Trial
IGF-1 and Bone Loss in Women With Anorexia Nervosa NA Anorexia nervosa is an eating disorder that can cause thinning of the bones...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture PHASE4 This study will evaluate whether teriparatide is superior to the active com...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover PHASE3 The effects of stopping long-term (7 years) and short term (2 years) risedr...
Show More Location
Investigational Site
Learn More & Join Trial
Post-menopausal Women Osteoporosis(Phase III) PHASE3 The purpose of this study is to evaluate the efficacy and the safety of Ris...
Show More Location
Chung-ang university hospital
Learn More & Join Trial